EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, China Meheco Group Co's enterprise value is ¥18,840 Mil.
China Meheco Group Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ¥1,277 Mil. Therefore, China Meheco Group Co's EV-to-EBITDA for today is 14.76.
The historical rank and industry rank for China Meheco Group Co's EV-to-EBITDA or its related term are showing as below:
SHSE:600056'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.76 Med: 13.74 Max: 34.14
Current: 14.76
During the past 13 years, the highest EV-to-EBITDA of China Meheco Group Co was 34.14. The lowest was 4.76. And the median was 13.74.
SHSE:600056's EV-to-EBITDA is ranked worse than 75.31% of 81
companies
in the Medical Distribution industry
Industry Median: 9.95
vs SHSE:600056: 14.76
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
China Meheco Group Co EV-to-EBITDA Historical Data
The historical data trend for China Meheco Group Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of China Meheco Group Co's EV-to-EBITDA
For the Medical Distribution subindustry, China Meheco Group Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Meheco Group Co's EV-to-EBITDA Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China Meheco Group Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where China Meheco Group Co's EV-to-EBITDA falls into.
China Meheco Group Co's current Enterprise Value is ¥18,840 Mil.
China Meheco Group Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,277 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Meheco Group Co (SHSE:600056) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
China Meheco Group Co's PE Ratio for today is calculated as:
China Meheco Group Co's share price for today is ¥11.38.
China Meheco Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.377.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of China Meheco Group Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
China Meheco Group Co (SHSE:600056) Business Description
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, logistics to international trading, academic promotion and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:600056 has been successfully added to your 